Found: 7
Select item for more details and to access through your institution.
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03308-w
- By:
- Publication type:
- Article
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 8, p. 1, doi. 10.1038/s41419-018-0811-7
- By:
- Publication type:
- Article
Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5788, doi. 10.3390/ijms21165788
- By:
- Publication type:
- Article
Nanoparticles Loaded with Wnt and YAP/Mevalonate Inhibitors in Combination with Paclitaxel Stop the Growth of TNBC Patient‐Derived Xenografts and Diminish Tumorigenesis.
- Published in:
- Advanced Therapeutics, 2020, v. 3, n. 11, p. 1, doi. 10.1002/adtp.202000123
- By:
- Publication type:
- Article
Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 6, p. 271, doi. 10.1093/jcag/gwac020
- By:
- Publication type:
- Article
Short-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2022, v. 5, n. 6, p. 251, doi. 10.1093/jcag/gwac009
- By:
- Publication type:
- Article
At the Intersection of Cardiology and Oncology: TGFβ as a Clinically Translatable Therapy for TNBC Treatment and as a Major Regulator of Post-Chemotherapy Cardiomyopathy.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1577, doi. 10.3390/cancers14061577
- By:
- Publication type:
- Article